--- title: "China NT Pharma Group Co. (1011) stock and investor profile" url: "https://aibio.space/companies/china-nt-pharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "China NT Pharma Group Co., Ltd. (HKEX: 1011), Hong Kong. The directory classifies it as Biotechnology." --- 1011 China NT Pharma Group Co., Ltd. HKEX · Hong Kong # China NT Pharma Group Co. (1011) news China NT Pharma Group Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1011, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest China NT Pharma Group Co. news We have not published a story on China NT Pharma Group Co. yet. When there is news, it will appear here. ## China NT Pharma Group Co. at a glance - **Ticker**: 1011 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Sirnaomics](https://aibio.space/companies/sirnaomics/) HKEX: 2257 - [SinoMab Bioscience](https://aibio.space/companies/sinomab-bioscience/) HKEX: 3681 - [CPBIO Holding Company](https://aibio.space/companies/cpbio/) HKEX: 3839 - [Genscript Biotech](https://aibio.space/companies/genscript-biotech/) HKEX: 1548 - [Sanai Health Industry Group Company](https://aibio.space/companies/sanai-health-industry/) HKEX: 1889 - [China Traditional Chinese Medicine Holdings Co.](https://aibio.space/companies/china-traditional-chinese-medicine/) HKEX: 570 - [Lee's Pharmaceutical Holdings](https://aibio.space/companies/lee-s-pharmaceutical/) HKEX: 950 - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) HKEX: 8037 ### Also on HKEX - [Luye Pharma Group](https://aibio.space/companies/luye-pharma/) 2186 - [SSY Group](https://aibio.space/companies/ssy/) 2005 - [Hansoh Pharmaceutical Group Company](https://aibio.space/companies/hansoh-pharmaceutical/) 3692 - [New Ray Medicine International Holding](https://aibio.space/companies/new-ray-medicine-international/) 6108 - [Kintor Pharmaceutical](https://aibio.space/companies/kintor-pharmaceutical/) 9939 - [Viva Biotech Holdings](https://aibio.space/companies/viva-biotech/) 1873 ## Questions about China NT Pharma Group Co. What is the ticker symbol of China NT Pharma Group Co.? China NT Pharma Group Co., Ltd. trades under the ticker 1011 on HKEX. Where is China NT Pharma Group Co. listed? China NT Pharma Group Co., Ltd. is listed on HKEX. Which country or territory is China NT Pharma Group Co. listed under? Our directory records China NT Pharma Group Co., Ltd. under Hong Kong. What does China NT Pharma Group Co. do? Our directory classifies China NT Pharma Group Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of China NT Pharma Group Co.? The ISIN recorded for China NT Pharma Group Co., Ltd. is KYG2114L1133. Does aibio.space cover China NT Pharma Group Co.? aibio.space lists China NT Pharma Group Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to China NT Pharma Group Co.? Companies in our directory listed in the same country and business area as China NT Pharma Group Co.: Sirnaomics, SinoMab Bioscience, CPBIO Holding Company, Genscript Biotech, Sanai Health Industry Group Company, China Traditional Chinese Medicine Holdings Co.. ## Investor discussion: China NT Pharma Group Co. Members talk about China NT Pharma Group Co. (1011). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at China NT Pharma Group Co., newest first. Each line links the filing it comes from. 1. 2026-09-04 Financings Share or debt issue: COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090401929.pdf) 2. 2026-08-10 Financings Share or debt issue: CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE, APPOINTMENT OF AUDITOR AND NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081000290.pdf) 3. 2026-07-31 Financings Share or debt issue: FURTHER DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073101597.pdf) 4. 2026-07-10 Financings Share or debt issue: DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0710/2026071000293.pdf) 5. 2026-07-03 Mergers Transaction under the Listing Rules: UPDATE ON IMPLEMENTATION OF REMEDIAL ACTIONS AND KEY FINDINGS OF INTERNAL CONTROL REVIEW. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070302583.pdf) 6. 2026-06-17 Financings Share or debt issue: CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0617/2026061701714.pdf) 7. 2026-05-11 Mergers Transaction under the Listing Rules: PAST NOTIFIABLE TRANSACTIONS AND CONNECTED TRANSACTIONS IN RELATION TO THE PROVISION OF FINANCIAL ASSISTANCE AND LOAN AGREEMENTS AND DISCLOSURE OF JUDICIAL PROCEDURE RECORDS OF A DIRECTOR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0511/2026050801768.pdf) 8. 2026-05-08 Mergers Transaction under the Listing Rules: PAST NOTIFIABLE TRANSACTIONS AND CONNECTED TRANSACTIONS IN RELATION TO THE PROVISION OF FINANCIAL ASSISTANCE AND LOAN AGREEMENTS AND DISCLOSURE OF JUDICIAL PROCEDURE RECORDS OF A DIRECTOR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0508/2026050801768.pdf) 9. 2026-03-25 Mergers Transaction under the Listing Rules: COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032501249.pdf) 10. 2026-02-11 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0211/2026021100067.htm) 11. 2026-02-10 Listings Trading status: TERMINATION OF THE SUBSCRIPTION AGREEMENTS IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0210/2026021001434.pdf) 12. 2026-02-10 Listings Trading status: TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0210/2026021000225.pdf) 13. 2026-02-10 Listings Trading status: EXCHANGE NOTICE - TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0210/2026021000119.htm) 14. 2026-02-09 Financings Share or debt issue: ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0210/2026021000051.pdf) 15. 2025-12-24 Mergers Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1224/2025122400399.pdf) 16. 2025-12-18 Mergers Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1218/2025121801453.pdf) 17. 2025-08-20 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0820/2025082000115.htm) 18. 2025-08-19 Listings Trading status: INSIDE INFORMATION AND RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081901660.pdf) 19. 2025-08-19 Listings Trading status: TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081901386.pdf) 20. 2025-08-19 Listings Trading status: EXCHANGE NOTICE - TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0819/2025081900211.htm) 21. 2025-06-30 Mergers Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0630/2025063004106.pdf) 22. 2025-04-29 Mergers Transaction under the Listing Rules: CLARIFICATION ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0429/2025042900433.pdf) 23. 2025-04-28 Mergers Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042804093.pdf) 24. 2025-02-21 Mergers Transaction under the Listing Rules: COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0221/2025022100845.pdf) 25. 2025-02-17 Mergers Transaction under the Listing Rules: (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 17 FEBRUARY 2025; AND (2) GRANT OF WHITEWASH WAIVER. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0217/2025021701007.pdf) 26. 2025-02-04 Mergers Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0204/2025020401473.pdf) 27. 2025-01-28 Mergers Transaction under the Listing Rules: DESPATCH OF THE CIRCULAR IN RELATION TO (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE; (2) APPLICATION FOR WHITEWASH WAIVER; AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0128/2025012800585.pdf) 28. 2025-01-27 Mergers Transaction under the Listing Rules: (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE; (2) APPLICATION FOR WHITEWASH WAIVER; AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0127/2025012701029.pdf) 29. 2025-01-20 Mergers Transaction under the Listing Rules: MONTHLY UPDATE ANNOUNCEMENT ON (1) CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE; AND (2) APPLICATION FOR WHITEWASH WAIVER. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0120/2025012001188.pdf) 30. 2025-01-08 Mergers Transaction under the Listing Rules: PROFIT WARNING AND INSIDE INFORMATION ANNOUNCEMENT UPDATE ON FINANCIAL INFORMATION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0108/2025010800540.pdf) ## Press releases Headlines of China NT Pharma Group Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-23 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT SUPPLEMENTAL INFORMATION IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301304.pdf) 2. 2026-10-20 HKEXnews [Notification Letter and Request Form to Non-Registered Holder](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100041.pdf) 3. 2026-10-20 HKEXnews [Notification Letter and Reply Form to Registered Shareholder](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100035.pdf) 4. 2026-10-20 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100029.pdf) 5. 2026-10-20 HKEXnews [APPOINTMENT OF AUDITOR AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1021/2026102100027.pdf) 6. 2026-09-25 HKEXnews [VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPLICATION FOR COMPULSORY ENFORCEMENT BY A WHOLLY-OWNED SUBSIDIARY IN RESPECT OF THE SHAREHOLDERS' RIGHT TO INFORMATION OF BEIJING KANGCHEN BIOLOGICAL TECHNOLOGY CO., LIMITED](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0925/2026092501109.pdf) 7. 2026-09-25 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT ARBITRATION AWARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0925/2026092500919.pdf) 8. 2026-09-14 HKEXnews [APPOINTMENT OF AUDITOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0914/2026091401185.pdf) 9. 2026-09-04 HKEXnews [COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090401929.pdf) 10. 2026-08-31 HKEXnews [CHANGE OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) PROCESS AGENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083102237.pdf) 11. 2026-08-28 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 28 AUGUST 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082804270.pdf) 12. 2026-08-20 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0820/2026082001619.pdf) 13. 2026-08-18 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT ARBITRATION AWARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0818/2026081801923.pdf) 14. 2026-08-10 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 15. 2026-08-10 HKEXnews [CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALISATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE, APPOINTMENT OF AUDITOR AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0810/2026081000290.pdf) 16. 2026-07-31 HKEXnews [QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073102035.pdf) 17. 2026-07-31 HKEXnews [FURTHER DELAY IN DESPATCH OF CIRCULAR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073101597.pdf) 18. 2026-07-10 HKEXnews [DELAY IN DESPATCH OF CIRCULAR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0710/2026071000293.pdf) 19. 2026-07-03 HKEXnews [UPDATE ON IMPLEMENTATION OF REMEDIAL ACTIONS AND KEY FINDINGS OF INTERNAL CONTROL REVIEW](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070302583.pdf) 20. 2026-07-03 HKEXnews [CHANGE OF CHIEF EXECUTIVE OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0703/2026070302561.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1011 on TradingView](https://www.tradingview.com/symbols/HKEX-1011/). ## Listing details China NT Pharma Group Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1011, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: China NT Pharma Group Co., Ltd. - **Ticker**: 1011 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Biotechnology - **ISIN**: KYG2114L1133 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1011/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/china-nt-pharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "China NT Pharma Group Co. (1011) stock and investor profile", 2026-10-31, https://aibio.space/companies/china-nt-pharma/